Re:Soluble ACE2 shows promise for treating severe Covid19
by CameronNemo on Friday November 06, 2020 @07:45PM
(#25012449)
Problem is that the benefits of license free medicine to society are diffuse, while the benefits of a licensing fee are concentrated. That makes lobbying and organization/cooperation much easier for the entity that is developing the medicine.
The public is not as likely to organize their interests and establish a competent lobbying strategy. Just not enough in it for a single person for them to pay attention.
The public is not as likely to organize their interests and establish a competent lobbying strategy. Just not enough in it for a single person for them to pay attention.